MENU
+Compare
SVRA
Stock ticker: NASDAQ
AS OF
Aug 4 closing price
Price
$2.57
Change
-$0.02 (-0.77%)
Capitalization
444.19M

SVRA Savara Forecast, Technical & Fundamental Analysis

Savara Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SVRA with price predictions
Aug 04, 2025

SVRA in -3.76% downward trend, declining for three consecutive days on July 30, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SVRA declined for three days, in of 263 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where SVRA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

SVRA broke above its upper Bollinger Band on July 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 22, 2025. You may want to consider a long position or call options on SVRA as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

SVRA moved above its 50-day moving average on July 23, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SVRA crossed bullishly above the 50-day moving average on July 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SVRA advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 161 cases where SVRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.004) is normal, around the industry mean (17.871). P/E Ratio (0.000) is within average values for comparable stocks, (58.473). SVRA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.530). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (278.698).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SVRA is expected to report earnings to rise 2.08% to -12 cents per share on August 07

Savara SVRA Stock Earnings Reports
Q2'25
Est.
$-0.12
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.02
Q3'24
Est.
$-0.11
Q2'24
Missed
by $0.02
The last earnings report on May 13 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 1.24M shares outstanding, the current market capitalization sits at 444.19M.
A.I. Advisor
published General Information

General Information

a pharmaceuticals developer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1717 Langhorne Newtown Road
Phone
+1 512 614-1848
Employees
37
Web
https://www.savarapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PUMYX15.04N/A
N/A
PACE Small/Medium Co Growth Equity Y
LAMYX24.47N/A
N/A
Lord Abbett Dividend Growth I
AIWEX16.41N/A
N/A
Cavanal Hill World Energy Institutional
BDHIX8.74N/A
N/A
BlackRock Dynamic High Income Instl
GEICX7.17N/A
N/A
Gabelli Equity Income C

SVRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-0.77%
RCKT - SVRA
62%
Loosely correlated
+2.68%
PRTA - SVRA
46%
Loosely correlated
+1.91%
RVMD - SVRA
41%
Loosely correlated
+1.50%
CCCC - SVRA
40%
Loosely correlated
-0.94%
CRNX - SVRA
39%
Loosely correlated
+1.36%
More